The Science Behind Targeted Treatments and Immunotherapies for Malignant Melanoma

Description: A one-day course on the biology and genetics of malignant melanoma and the science behind the latest treatment approaches. Both BRAF/MEK inhibitors and checkpoint inhibitors will be explained and the latest trial data presented. The day will also include an overview of novel treatments such as antigen and DNA vaccines and other agents in early phase trials.
Level: Intermediate/Advanced
Audience: Ideal for pharmacists, research nurses, pharmaceutical companies, junior doctors or anyone who has been on one of Elaine’s other courses
To book, contact:
View the day’s programme

Book your place on the Marsden’s website